WO2010128519A1 - A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus - Google Patents
A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus Download PDFInfo
- Publication number
- WO2010128519A1 WO2010128519A1 PCT/IN2009/000720 IN2009000720W WO2010128519A1 WO 2010128519 A1 WO2010128519 A1 WO 2010128519A1 IN 2009000720 W IN2009000720 W IN 2009000720W WO 2010128519 A1 WO2010128519 A1 WO 2010128519A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- diabetic
- pressure
- predicting
- foot
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 30
- 238000011161 development Methods 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 16
- 208000003790 Foot Ulcer Diseases 0.000 title claims abstract description 13
- 208000033808 peripheral neuropathy Diseases 0.000 title claims abstract description 12
- 201000001119 neuropathy Diseases 0.000 title claims abstract description 11
- 230000007823 neuropathy Effects 0.000 title claims abstract description 11
- 206010040943 Skin Ulcer Diseases 0.000 title claims abstract description 7
- 230000036541 health Effects 0.000 title claims abstract description 7
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 6
- 208000025865 Ulcer Diseases 0.000 claims description 14
- 239000011521 glass Substances 0.000 claims description 11
- 231100000397 ulcer Toxicity 0.000 claims description 10
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 210000005036 nerve Anatomy 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 238000011002 quantification Methods 0.000 claims 1
- 210000002683 foot Anatomy 0.000 description 34
- 210000003371 toe Anatomy 0.000 description 10
- 206010033546 Pallor Diseases 0.000 description 7
- 208000004210 Pressure Ulcer Diseases 0.000 description 7
- 206010056697 Tissue anoxia Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 230000036269 ulceration Effects 0.000 description 4
- 206010056340 Diabetic ulcer Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000008960 Diabetic foot Diseases 0.000 description 2
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000005291 chaos (dynamical) Methods 0.000 description 2
- 230000000739 chaotic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000001255 hallux Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000024980 claudication Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000010984 neurological examination Methods 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000453 second toe Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000000431 third toe Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/1036—Measuring load distribution, e.g. podologic studies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/447—Skin evaluation, e.g. for skin disorder diagnosis specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6829—Foot or ankle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- This present invention relates to development of a new device using the revolutionary chaos theory to diagnose conditions like neuropathy and predict possibility of ulcer development in various health conditions especially like diabetes etc.
- the object of the invention is to prove that foot ulceration is linked to the sustenance of pressure rather than the degree plantar pressure, since very little pressure is required to cause capillary blanching. Tissue anoxia thus should occur if the pressure continues to cause blanching rather than a large pressure that disappears occasionally and does not cause sustained tissue anoxia.
- the further object of the invention is to show the effect that there is a continuous temporal plantar weight bearing foci in healthy individuals, which ensures that high pressure is exerted on the feet which do not hinder the capillary circulation of blood to any part of the feet continuously for extended periods even while standing.
- the invention provides a method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus, consisting of glass slab, mounting stand, a camera, led light and computer equipped with CGN Data analyzer and report generator software.
- the present invention also quantifies the amount of temporal, variation and shift of plantar pressure bearing points by using skin capillary colour change
- Figure 1 represents the overall assembly of Glass Slab (1), measuring 12 mm thick and 40 cm length and 40 cm breadth.
- the glass with tolerance of weight up to 200 Kg
- mounting stand (2) made of metal, plastic or wood with dimensions 45cm in breadth and 45cm length and 50cm in height, capable bearing of upto 300kg
- camera (3) placed beneath the glass slab.
- the camera should be of 5 megapixels or above.
- the camera should be positioned to record the video of both feet when a patient stands on the glass slab (1).
- the camera should view from the operator's computer and the person standing on the glass slab should be instructed to expose their feet to the camera.
- Light emitting diode (LED) lights (4) are placed below the mounting stand to supply light for camera recording. Usually 10 LED lights on right and 10 LED lights on left are sufficient are enough to allow camera recording and computer (5) for primation of graph.
- LED Light emitting diode
- FIG. 2 illustrates the computer ( 5) equipped with CGN Video to Image converter & CGN Data analyzer and report generator, where the image of the feet of patient is displayed (6).
- Figure 3 illustrate the graph (8) obtained when normal healthy person stand on the arrangement referred in figure 1, graph (9) obtained when diabetic patient stand on the same.
- Figure 4 Illustrate the mean distances of the centre of these points with reference to Mayer's line in controls (4a) and diabetic individuals (4b.)
- the DI (diabetic individual), time series has fewer fluctuations and lower magnitude that that of controls.
- the patient is made to stand on the glass slab (1), mounted on a mounting stand (2), the camera (3) fixed beneath the glass slab, connected to the computer (5).
- the camera after recording the video of the patient feet transfers the images to the computer at specific intervals of time.
- at least ten markings (points) are made (7) .
- comparison a graph (9) is displayed on all nonlinear of all the selected points, predicting the nerve condition of the possibility of the ulcer development in the diabetic patient.
- Diabetic foot syndrome is perhaps one of the most important complications of diabetes mellitus.
- the prevalence of diabetic foot ulcers ranges between 4- 10%, while the lifetime incidence rates may be as high as 25% (Ref-1).
- a number of factors like the peripheral vascular disease, changes in foot architecture, peripheral sensory neuropathy and the plantar pressure are considered to be the prime etiological factors for the development of ulcers
- the present invention is of the aim to compare and quantify temporal redistribution of plantar pressure points (areas of capillary blanching) between normal subjects and DI with no clinical signs of neuropathy.
- the points were: a) The lowest point of the pale area on the 2 nd toe. b) The lowest point of the pale area on the 3 rd toe. c) The lowest point of the pale area on the 4 th toe. d) The lowest point of the pale area on the 5 th toe. e) A point to the left of the mid-point of the Meyer's lines (an anatomical line passing through the middle of the great toe and the heel). f) A point to the right of the mid-point of the Meyer's line. g) A point 2 cm above the base of heel, to the left of Meyer's line. h) A point 2cm above the base of heel, to the right of Meyer's line. i) A point on the Meyer's line corresponding to the lower limit of the pale area on the foot. j) A point on the Meyer's line corresponding to 5 the upper limit of the pale area on the foot
- SDPP standard deviation of difference between consecutive redistribution of centre of the pressure point (SDPP) in cm. SDPP was used rattier than raw distances since it is invariant to foot size.
- Table 1 Demographic data of controls and diabetic patients.
- SDPP Standard deviation of difference between consecutive pressure points in cms.;FD: Fractal dimension; DI: Diabetic individuals.
- the variation in the frequency of redistribution in different areas of the foot may pose a higher risk of ulcer formation in some specific parts of the foot.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus, by providing a an arrangement for recording the image of the feet of patient comprising a transparent mounting stand (2), a camera (3) connected to computer (5) equipped with Video to Image converter, Data analyzer and report generator. Once the patient stands on the mounting stand; images are displayed on computer, markings on the displayed images allow the prediction of development in the diabetic patient.
Description
Title Of The Invention:
A Method For Detecting Neuropathy And Predicting Foot Ulcer Development In Human Beings With Health Conditions Like Diabetes Mellitus Field Of Invention:
This present invention relates to development of a new device using the revolutionary chaos theory to diagnose conditions like neuropathy and predict possibility of ulcer development in various health conditions especially like diabetes etc.
State Of The Art In The Field And Description Of Prior Art:
It is believed that the high pressure point areas on the foot are at a higher risk for developing plantar ulcers. Therefore it is believed that development of foot ulcers in diabetes is related to amount of pressure exerted on a given point of the feet and accordingly medicines are prescribed and treatments are given by the Doctors all over the world. If one goes by this belief it is surprising as all the athletes and actively playing young adults should develop pressure ulcers as they are exerting themselves while playing and develop higher amount of plantar
pressure than any other normal diabetic patient.
Therefore, there is a flaw in the present system of diagnosing a diabetic patient particularly or planter ulcers. So for no research has been conducted to detect cause for foot ulcer and the present invention is aimed to develop a successful method to detect the same scientifically and accurately without any flaw.
Object of the Invention (problem and solution): The object of the invention is to prove that foot ulceration is linked to the sustenance of pressure rather than the degree plantar pressure, since very little pressure is required to cause capillary blanching. Tissue anoxia thus should occur if the pressure continues to cause blanching rather than a large pressure that disappears occasionally and does not cause sustained tissue anoxia. The further object of the invention is to show the effect that there is a continuous temporal plantar weight bearing foci in healthy individuals, which ensures that high pressure is exerted on the feet which do not hinder the capillary circulation of blood to any part of the feet continuously for extended periods even while standing. It is also believed that this physiological
temporal variation and shift of weight bearing foci which ensures circulation to every part of feet disappears in a person suffering from diabetics there by leading to continuous deprivation of blood supply to some parts of the feet bearing weight continuously, which leads to development of diabetic ulcers. Another object of the invention is development of method to quantify the amount of temporal variations to diagnose diabetic neuropathy and predict the probable ulcer development areas in the feet of diabetics and to initiate preventive measures to delay or totally stop the path physiological processes responsible for formation of diabetic ulcers. Statement of the invention:
Accordingly the invention provides a method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus, consisting of glass slab, mounting stand, a camera, led light and computer equipped with CGN Data analyzer and report generator software.
Characterized in that, the principles of chaos theory is used to explain the cause of development of
pathology, wavelets and fractal deviations and nonlinear methods are adopted to predict ulcer development and generates reports.
The present invention also quantifies the amount of temporal, variation and shift of plantar pressure bearing points by using skin capillary colour change
(which clearly indicates circulation to the skin without any ambiguity) over the from blanching to pink. Whereas in earlier inventions mainly quantifies the amount of pressure.
Detailed description of the drawings: Hardware Part
Figure 1 represents the overall assembly of Glass Slab (1), measuring 12 mm thick and 40 cm length and 40 cm breadth. The glass with tolerance of weight up to 200 Kg, mounting stand (2) made of metal, plastic or wood with dimensions 45cm in breadth and 45cm length and 50cm in height, capable bearing of upto 300kg, camera (3) placed beneath the glass slab. The camera should be of 5 megapixels or above. The camera should be positioned to record the video of both feet when a patient stands on the glass slab (1). The camera should view from the operator's computer and the
person standing on the glass slab should be instructed to expose their feet to the camera. Light emitting diode (LED) lights (4) are placed below the mounting stand to supply light for camera recording. Usually 10 LED lights on right and 10 LED lights on left are sufficient are enough to allow camera recording and computer (5) for analization of graph.
Software Figure 2 Figure 2 illustrates the computer ( 5) equipped with CGN Video to Image converter & CGN Data analyzer and report generator, where the image of the feet of patient is displayed (6).
Figure 3 Figure 3 illustrate the graph (8) obtained when normal healthy person stand on the arrangement referred in figure 1, graph (9) obtained when diabetic patient stand on the same.
Figure4. Figure 4 Illustrate the mean distances of the centre of these points with reference to Mayer's line in controls (4a) and diabetic individuals (4b.) The DI (diabetic individual), time series has fewer
fluctuations and lower magnitude that that of controls.
Detailed description of the invention with reference to the drawings: The patient is made to stand on the glass slab (1), mounted on a mounting stand (2), the camera (3) fixed beneath the glass slab, connected to the computer (5). The camera after recording the video of the patient feet transfers the images to the computer at specific intervals of time. Once the images are displayed on computer, at least ten markings (points) are made (7) . After analysis, comparison a graph (9) is displayed on all nonlinear of all the selected points, predicting the nerve condition of the possibility of the ulcer development in the diabetic patient.
Diabetic foot syndrome is perhaps one of the most important complications of diabetes mellitus. The prevalence of diabetic foot ulcers ranges between 4- 10%, while the lifetime incidence rates may be as high as 25% (Ref-1). A number of factors like the peripheral vascular disease, changes in foot architecture, peripheral sensory neuropathy and the plantar pressure are considered to be the prime
etiological factors for the development of ulcers
(Ref -2, 3). Studies in the past have demonstrated that, the capillary flow is increased rather than decreased in the diabetic neuropathic foot and the high pressure areas are presumed to be associated with increased basal skin blood flow as compared to low pressure areas (Ref-4-6)). Currency it is believed that the development of plantar pressure ulcers is associated with high amount of pressure exerted on certain regions of the foot (Ref-7-9). Considering the minimal amount of pressure (<30 mm Hg) required to occlude the capillary flow, any pressure greater than this is likely to cause an ulcer. It would be more appropriate to suspect the prolonged sustenance of pressure at particular points causing unremitting tissue anoxia at these points rather than its magnitude as the prime cause for plantar ulcers. In our previous study we had demonstrated the role of redistribution of the pressure points or the weight bearing points in preventing the development of pressure ulcers in healthy individuals (Ref-10). The possible disruption of this bio-mechanism in diabetics owing to peripheral neuropathy may lead to the development of pressure ulcers in susceptible individuals. As sub-clinical neuropathy is may exist
for long periods in diabetic individuals (DI)
(Ref :11) we hypothesize that the loss of redistribution of pressure points may precede evidence of clinical neuropathy. The present invention is of the aim to compare and quantify temporal redistribution of plantar pressure points (areas of capillary blanching) between normal subjects and DI with no clinical signs of neuropathy.
Methods This study was conducted at a premiere university teaching hospital in South India. The protocol of the study was approved by the Institute ethics committee. Written informed consent was obtained from each subject. Three adult male and 1 female diagnosed to have Type-2 Diabetes as per the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus criteria were selected (Ref 12). Patients underwent routine outpatient neurological examination. None of the patients were found to have any abnormalities in sensation or muscle weakness or any evidence of claudication pain. Age matched healthy male individuals were included as controls. The subjects were asked to stand on a transparent plexiglass slab of thickness 12mm. A
digital video camera (5 megapixel camera) was placed 42cm below the glass slab and a 10 minute video recordings of the plantar area was done for each of the study participants. Offline analysis of the images at every 10 second intervals was done. Ten pressure points (areas of capillary blanching) were selected from the right foot of all subjects. These pressure points were chosen from our previous study, analyzing pressure point changes in normal subjects. The measured points are detailed below.
The points were: a) The lowest point of the pale area on the 2nd toe. b) The lowest point of the pale area on the 3rd toe. c) The lowest point of the pale area on the 4th toe. d) The lowest point of the pale area on the 5th toe. e) A point to the left of the mid-point of the Meyer's lines (an anatomical line passing through the middle of the great toe and the heel). f) A point to the right of the mid-point of the Meyer's line. g) A point 2 cm above the base of heel, to the left of Meyer's line. h) A point 2cm above the base of heel, to the right of Meyer's line.
i) A point on the Meyer's line corresponding to the lower limit of the pale area on the foot. j) A point on the Meyer's line corresponding to 5 the upper limit of the pale area on the foot
Measurement of perpendicular distances of the first eight points with reference to Mayer's line and of the last 2 points with reference to the lowest point on the heel (also the lowest 10 point on the Meyer's line) was done at every
10 seconds. A total of 60 measurements were obtained per point per subject.
For each point the following parameters were calculated:
15 a) Standard deviation of difference between consecutive redistribution of centre of the pressure point (SDPP) in cm. SDPP was used rattier than raw distances since it is invariant to foot size.
20 b) Fractal dimension (FD) as described by Katz,
1988 (13) FD = log (N-l)÷ [log (N-I) + log (d/L)]
N = Number of samples (Le. 60), d = Maximum & L = Total 'distance' on waveform. FD (range 1-2) itself has no units. Statistical Analysis
All statistical analysis were done using SPSS version 11. Continuous variables were expressed as mean ± standard deviation. Comparison of parameters between patients and controls was performed using Mann-Whitney U test for exact significance values.
Results :
Demographics of the subjects are shown in Table 1. The age range for DI was 41-51 years and 38-47 years for controls. Duration of illness for DI at diagnosis ranged from 132-192 months. (25.1+0.98 kg/m2) (23.6±0.49 kg/m2) Figure 4 depicts the mean distances of the centre of these points with reference to Mayer's line DI and control subjects Overall variability is higher in normal individuals when compared to diabetics.
Comparison of combined points show SDPP (DI =0.013 ± 0.008 cm, controls= 0.196+0.233 cm, P <0.001) and FD (DI =1.000 ± 0.000, controls=
1.010+0.017, P <0.001) of diabetic patients to be significantly lower than controls. On examination of individual pressure points, (Table 2) two pressure points on the plantar aspect of the foot in diabetics (point 3,8) (pressure point at base of 4th toe ,right of the midpoint of Meyer's line appear to have similar SDPP and FD in both patients and controls and do not reach significance levels. The FD of point 1 (base of second toe) is comparable between diabetics and controls.
Table 1: Demographic data of controls and diabetic patients.
DI: Diabetic individuals
Table2: Statistical and Fractal Dimensional comparison between Diabetic individuals and controls
SDPP: Standard deviation of difference between consecutive pressure points in cms.;FD: Fractal dimension; DI: Diabetic individuals. Pressure points
(1: The lowest point of the pale area on the 2nd toe. 2: The lowest point of the pale area on the 3rd toe. 3: The lowest point of the pale area on the 4th toe. 4: The lowest point of the pale area on the 5th toe. 5: A pressure point to the left of the mid-point of the Meyer's line (an anatomical line passing through the middle of the great toe and the heel).6: A pressure point to the right of the mid-point of the Meyer's line. 7: A point 2 cms above the base of heel, to the left of Meyer's line. 8: A point 2 cms above the base of heel, to the right of Meyer's line. 9: A point on the Meyer's line corresponding to the lower limit of the pale area on the foot. 10: A point on the Meyer's line corresponding to the upper limit of the pale area on the foot)
The present study shows that . even in a single individual there is variability in the magnitude of redistribution of weight bearing points (Figure 4). Redistribution appears to form a complex time series in normal individuals. In DI this is lost giving rise to a monotonous time series. The resultant waveforms of DI has less fluctuations and lower magnitude that that of controls. The SDPP is a useful measure at it minimizes the affect of foot size and shape. The
results suggest that point 3 and 8 (pressure point at base of 4th toe, right of the midpoint of Meyer's line, have the least variability of redistribution in both controls and diabetics. These points thus can be presumed to be the points through which maximum weight channelized and thus balance is obtained. These points lie along the lateral osseous ridge and give rise to the observation that pressure ulcers occur under osseous pressure points (7-9). Pressure changes appear chaotic in nature and do not follow any set pattern. The overall frequency and magnitude of the redistribution of these points is significantly less in diabetics as compared to healthy individuals, demonstrated by both fractal dimension and statistical measures. As fractal dimension is related to other nonlinear measures of chaos like correlation dimension, maximal Liapunov exponent, we expect that these measures too would be lower in diabetic individuals (DI). It would a much larger time series to calculate these measures and may require image processing tools to extract higher frequency changes. It may be concluded that the causation of diabetic ulcers or pressure ulcers may be the result of loss of mechanisms leading to
generation of chaos in the pressure distribution in feet.
This in contrast to the popular belief that the development of foot ulcers is related to the amount of pressure at a given point (8,9). We suggest a more intuitively plausible causality for foot ulceration. Ulceration may be linked to the sustenance of pressure rather than the degree as evidenced that very little pressure is required to cause capillary blanching. Tissue anoxia thus should occur if the pressure continues to cause blanching rather than a large pressure that disappears occasionally and does not cause sustained tissue anoxia.
The variation in the frequency of redistribution in different areas of the foot may pose a higher risk of ulcer formation in some specific parts of the foot.
These pressure points in the diabetics which display a low frequency of redistribution may be at a higher risk for development of plantar ulcers as compared to other parts of the foot. Points over the heel and third toe seem especially vulnerable with lower frequency of re distribution.
Earlier theories, proposing high pressure point areas on the foot to be at a higher risk for developing
plantar ulcers have led to several expensive diagnostic instruments for the recognition of such point (6,7). However, all such futuristic diagnostic technology may not be accessible to low income group patients in the in remote and economically challenged areas especially in the developing countries. Our method of analysis of such high risk points on the foot of diabetics is simple and inexpensive. Conclusion:
Our analysis of 10 selected points shows that the sites of low to minimal frequency of chaotic redistribution of these points is specific for an individual and may vary from person to person. There is impaired redistribution of plantar pressure points in individuals with diabetes without signs of clinical neuropathy. This can be attributed to loss of chaos generating mechanisms in DI. Redistribution of pressure points may be essential in the prevention of trophic ulcers in susceptible individuals. The recognition of such points through such simple techniques may even help low-end shoe manufacturers to design comfortable footwear for sensory neuropathy patients specific to their need
which shall provide them protection against the development of pressure ulcers. Scope of the invention:
Although the invention has been described with reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed, embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. It is therefore contemplated that such modifications can be made without departing from the spirit or scope of the present invention as defined. The flexibility of choosing as may be as many as 25,000 points in the feet.
References:
1. Singh N, Armstrong DG, Lipsky BA (2005). Preventing foot ulcers in patients with diabetes.JAMA. Jan 12;293(2):217-28
2. Richard JL, Schuldiner S. (2008
). Epidemiology of diabetic foot problems.Rev Med Interne Sep;29 2:S222-30
3. Boulton AJ (1992). The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia.^ Jul;35(7):660-3.
5 4. Netten PM, Wollersheim H, Thien T,
Lutterman JA. (1996) Skin microcirculation of the foot in diabetic neuropathy. CHn Sci.;91:559-565.
5. Flynn MD, Edmonds ME, Tooke JE, Watkins 10 PJ. (1988) Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia.;31 :652-656
6. Newton D J, Bennett S P , Fraser J, Khan F, Belch JJF , Griffiths G and Leese GP (2005).
15 Pilot study of the effects of local pressure on microvascular function in the diabetic foot. Diabetic Medicine 22; 11,1487 - 1491.
7. Mueller MJ, Zou D, Bohnert KL, Turtle LJ, Sinacore DR. (2008) Plantar stresses on the
20 neuropathic foot during barefoot walking.Phys Ther. Nov;88(ll):1375-84.
8. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. (1998) Choosing
a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med; 158:289-92
"5 9. Stess RM, Jensen SR, Mirmiran R. (1997) The role of dynamic plantar pressures in diabetic foot ulcers. Diabetes Care; 20:855-8.
10. Oberoi D V, Kumar C J, D'souza S, Kumar A, Hegde B M. (2007). Does non chaotic weight
10 bearing foci cause foot ulceration in diabetics?
Medical Hypotheses. 68(2), 468-9.
11. Hendriksen PH, Oey PL, Wieneke GH, Bravenboer B, and van Huffelen AC. (1993). Subclinical diabetic polyneuropathy: early
15 detection of involvement of different nerve fibre types. J Neurol Neurosurg Psychiatry. May; 56(5): 509-514.
12. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, et al.
20 (2002) Report of the Expert Committee on the
Diagnosis and Classification of DiabetesMellitus. Diabetes Care,;25 Suppl l:S5-S20.
13. Katz MZ.(1988) Fractals and analysis of waveforms. Comp Biol Med;18:145-156.
10
15
20
25
Claims
1. A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus, comprising steps of:
(a) providing a an arrangement ( fig 1 & 2) for recording the image of the feet of patient comprising of Glass Slab (1), mounting stand (2) camera (3), connected to computer (5) equipped with CGN Video to Image converter & CGN Data analyzer and report generator, wherein the image of the feet of patient is displayed at specific intervals of time, once the patient stands on the mounting stand;
(b) at least ten markings (points) are made (7) (fig-3) on the images are displayed on computer, analyzing , comparing the graph (9) between diabetic patient and normal individual, displayed on all nonlinear of all the selected points, predicting the nerve condition of the possibility of the ulcer development in the diabetic patient.
2. A method as claimed in claim 1, wherein the Glass Slab (1), measuring 12 mm thick and 40 cm length and- 40 cm breadth with tolerance of weight up to 200 Kg, mounting stand (2) made of metal, plastic or wood with dimensions 45cm in breadth and 45cm length and 50cm in height, capable bearing of up to 300kg, camera (3) of 5 megapixels or above, computer (5) equipped with CGN Video to Image converter & CGN
Data analyzer and report generator.
3 The method as claimed in preceding claims, wherein said electronic image comprises a color photocopy of the feet.
4. The method as claimed in preceding claims quantifies the progression of Diabetic Neuropathy, enabling the physician or the person authorized to perform this procedure and analyze the readings.
5. The method as claimed claim 4, wherein in the quantification in progression in diabetic neuropathy aids the physician to decide on the efficacy of a diabetic medication on a patient and decide appropriately on the treatment to ensue.
6. A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus, Substantially herein described with reference to drawings.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1028CH2009 | 2009-05-04 | ||
IN1028/CHE/2009 | 2009-05-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010128519A1 true WO2010128519A1 (en) | 2010-11-11 |
WO2010128519A4 WO2010128519A4 (en) | 2011-01-06 |
Family
ID=43050047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2009/000720 WO2010128519A1 (en) | 2009-05-04 | 2009-12-15 | A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010128519A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8293912B2 (en) | 2007-05-01 | 2012-10-23 | Chemagis Ltd. | Process for producing cisatracurium compounds and associated intermediates |
US8354537B2 (en) | 2007-10-29 | 2013-01-15 | Chemagis Ltd. | R,R1-atracurium salts |
US8357805B2 (en) | 2007-06-18 | 2013-01-22 | Chemagis Ltd. | (1R,1′R)-atracurium salts separation process |
US8357807B2 (en) | 2007-05-01 | 2013-01-22 | Chemagis Ltd. | Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates |
US8461338B2 (en) | 2007-03-08 | 2013-06-11 | Chemagis Ltd. | (1R, 1′R)-atracurium salts separation process |
US9301688B2 (en) | 2011-10-26 | 2016-04-05 | The United States of America, as Represented by Dept. of Veterans Affairs | System for screening the skin condition of the plantar surface of the feet |
US9737263B1 (en) | 2016-02-15 | 2017-08-22 | Wipro Limited | Footwear for monitoring health condition of foot of a user and a method thereof |
WO2020058217A1 (en) | 2018-09-17 | 2020-03-26 | Chiesi Farmaceutici S.P.A. | Agent for treatment of dermatological disorders |
CN111329484A (en) * | 2020-02-24 | 2020-06-26 | 华南理工大学 | Diabetic foot risk early warning device based on plantar pressure information time-space domain characteristics |
CN114068027A (en) * | 2020-07-29 | 2022-02-18 | 阿里巴巴集团控股有限公司 | Data processing method, data processing device, storage medium and computer equipment |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995012352A1 (en) * | 1993-11-04 | 1995-05-11 | Paromed Medizintechnik Gmbh | Device and process for ulcer prophylaxis and early recognition of neuropathy in the foot of a diabetic |
WO2004002309A1 (en) * | 2002-06-12 | 2004-01-08 | Medavinci Development B.V. | A device and method for checking a diabetic foot |
WO2005044105A1 (en) * | 2003-11-06 | 2005-05-19 | Sundaram Medical Foundation | Portable pedopowergraph |
-
2009
- 2009-12-15 WO PCT/IN2009/000720 patent/WO2010128519A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995012352A1 (en) * | 1993-11-04 | 1995-05-11 | Paromed Medizintechnik Gmbh | Device and process for ulcer prophylaxis and early recognition of neuropathy in the foot of a diabetic |
WO2004002309A1 (en) * | 2002-06-12 | 2004-01-08 | Medavinci Development B.V. | A device and method for checking a diabetic foot |
WO2005044105A1 (en) * | 2003-11-06 | 2005-05-19 | Sundaram Medical Foundation | Portable pedopowergraph |
Non-Patent Citations (1)
Title |
---|
RAHMAN M A ET AL.: "Analysis of plantar pressure in diabetic type 2 subjects with and without neuropathy", ITBM-RBM, EDITIONS SCIENTIFIQUES ET MEDICALES ELSEVIER, vol. 27, no. 2, 1 May 2006 (2006-05-01), pages 46 - 55, XP028073094, DOI: doi:10.1016/j.rbmret.2006.03.001 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8461338B2 (en) | 2007-03-08 | 2013-06-11 | Chemagis Ltd. | (1R, 1′R)-atracurium salts separation process |
US8293912B2 (en) | 2007-05-01 | 2012-10-23 | Chemagis Ltd. | Process for producing cisatracurium compounds and associated intermediates |
US8357807B2 (en) | 2007-05-01 | 2013-01-22 | Chemagis Ltd. | Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates |
US8357805B2 (en) | 2007-06-18 | 2013-01-22 | Chemagis Ltd. | (1R,1′R)-atracurium salts separation process |
US8354537B2 (en) | 2007-10-29 | 2013-01-15 | Chemagis Ltd. | R,R1-atracurium salts |
US9301688B2 (en) | 2011-10-26 | 2016-04-05 | The United States of America, as Represented by Dept. of Veterans Affairs | System for screening the skin condition of the plantar surface of the feet |
US9737263B1 (en) | 2016-02-15 | 2017-08-22 | Wipro Limited | Footwear for monitoring health condition of foot of a user and a method thereof |
WO2020058217A1 (en) | 2018-09-17 | 2020-03-26 | Chiesi Farmaceutici S.P.A. | Agent for treatment of dermatological disorders |
CN111329484A (en) * | 2020-02-24 | 2020-06-26 | 华南理工大学 | Diabetic foot risk early warning device based on plantar pressure information time-space domain characteristics |
CN114068027A (en) * | 2020-07-29 | 2022-02-18 | 阿里巴巴集团控股有限公司 | Data processing method, data processing device, storage medium and computer equipment |
Also Published As
Publication number | Publication date |
---|---|
WO2010128519A4 (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010128519A1 (en) | A method for detecting neuropathy and predicting foot ulcer development in human beings with health conditions like diabetes mellitus | |
Nightingale et al. | Validation of the timed up and go test for assessing balance variables in adults aged 65 and older | |
Kaminska et al. | The Epworth Sleepiness Scale: self‐administration versus administration by the physician, and validation of a French version | |
Chatchawan et al. | An exploration of the relationship between foot skin temperature and blood flow in type 2 diabetes mellitus patients: a cross-sectional study | |
Duan et al. | The effects of different accumulated pressure-time integral stimuli on plantar blood flow in people with diabetes mellitus | |
Benromano et al. | Physiological and behavioral responses to calibrated noxious stimuli among individuals with cerebral palsy and intellectual disability | |
Nasr et al. | Investigation of esophageal sensation and biomechanical properties in functional chest pain | |
Sun et al. | Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at‐risk feet | |
Mohr Drewes et al. | Central sensitization in patients with non-cardiac chest pain: a clinical experimental study | |
Moharić et al. | Sensitivity and specificity of von Frey's hairs for the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus | |
McRorie et al. | The relevance of large-vessel vascular disease and restricted ankle movement to the aetiology of leg ulceration in rheumatoid arthritis. | |
Bagherzadeh Cham et al. | Reliability of Semmes-Weinstein monofilaments and tuning fork on pressure and vibration sensation measurements in diabetic patients | |
Goit et al. | Cardiovascular autonomic function and vibration perception threshold in type 2 diabetes mellitus | |
Wu et al. | Effects of walking speeds and durations on peak plantar pressures | |
Bottini et al. | Variability and similarity of manual office and automated blood pressures | |
Midttun et al. | Heat‐washout–an objective method for diagnosing neuropathy and atherosclerosis in diabetic patients | |
Oberoi et al. | Temporal redistribution of plantar pressure points in diabetic and control subjects: A time-series analysis of neuro-capillary chaos | |
Oberoi et al. | Temporal Redistribution of Plantar Pressure Points in the Healthy and Diabetics: A Time Series Analysis of the Neuro-Capillary Chaos | |
KR20150065962A (en) | Method for assessing antipsychotic-induced side effects using heart rate variability | |
Holland | Risk Factors for High Blood Pressure | |
Marcoux et al. | Screening for Peripheral Arterial Disease: Tifflely use of the Leg Alert protocol in ambulatory patients can save lives. | |
Devmurari et al. | Effect of Sustained lsometric Handgrip Training on Blood Pressure in Normotensive and Prehypertensive Population | |
Suenaga et al. | Effects of stimulation by nostalgic images on heart rate variability | |
Fomina et al. | Photoplethysmography for non-invasive diagnosis of cold urticaria | |
Silva Junior et al. | Tissue oxygen saturation assessment during claudication symptoms in patients with peripheral arterial disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09844322 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09844322 Country of ref document: EP Kind code of ref document: A1 |